Literature DB >> 11598375

Procedure for neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

.   

Abstract

The value of screening of neonates for congenital adrenal hyperplasia is not universally accepted. Procedures for screening are recommended here in order to provide a structure to the testing and ultimately bring together data that will allow the effect of screening to be judged for benefit or dismissed as no better than clinical recognition of the disease state. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11598375     DOI： 10.1159/000049996

Source DB:  PubMed          Journal:  Horm Res        ISSN： 0301-0163


  4 in total

1.  Quality control requirements in neonatal screening.

Authors:  Toni Torresani
Journal:  Eur J Pediatr       Date:  2003-11-28       Impact factor: 3.183

2.  Lessons learned from 5 years of newborn screening for congenital adrenal hyperplasia in the Czech Republic: 17-hydroxyprogesterone, genotypes, and screening performance.

Authors:  Felix Votava; Dana Novotna; Petr Kracmar; Hana Vinohradska; Eva Stahlova-Hrabincova; Zuzana Vrzalova; David Neumann; Jana Malikova; Jan Lebl; Dietrich Matern
Journal:  Eur J Pediatr       Date:  2012-01-11       Impact factor: 3.183

3.  Complex Glycerol Kinase Deficiency and Adrenocortical Insufficiency in Two Neonates.

Authors:  Sabriye Korkut; Osman Baştuğ; Margarita Raygada; Nihal Hatipoğlu; Selim Kurtoğlu; Mustafa Kendirci; Charalampos Lyssikatos; Constantine A Stratakis
Journal:  J Clin Res Pediatr Endocrinol       Date:  2016-04-18

4.  Children with premature pubarche: is an alterated neonatal 17-Ohp screening test a predictive factor?

Authors:  Paolo Cavarzere; Margherita Mauro; Monica Vincenzi; Silvana Lauriola; Francesca Teofoli; Rossella Gaudino; Diego Alberto Ramaroli; Rocco Micciolo; Marta Camilot; Franco Antoniazzi
Journal:  Ital J Pediatr       Date:  2018-01-16       Impact factor: 2.638
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.